HOME >> MEDICINE >> NEWS
ESF sets out research strategy to push rheumatic diseases up the health agenda

Europe's experts in the field will hear the plan and discuss the recommendations at their annual meeting in Amsterdam this week.

Brussels, June 2006 The world's largest meeting of experts in rheumatic diseases will today hear and debate calls for a pan-European approach to prioritise and combine the efforts of many excellent scientific and clinical groups working at a national level, and accelerate research in the field.

The European League Against Rheumatism (EULAR) meeting in Amsterdam will be briefed on the findings of an expert group on rheumatic diseases, established by the ESF to set out research priorities for Europe, to improve treatments and prevent disease.

Stiff and aching joints may be accepted as an inevitable aspect of ageing, but the fact is that rheumatism is the leading cause of pain and disability in Europe, with approximately 100 million sufferers. Joint diseases account for half of all chronic conditions in over 65-year olds, a figure that will rise as the population ages.

And while these diseases are mainly afflictions of age, there is significant unmet medical need in paediatric rheumatism.

The cost of treatments and the economic loss caused by rheumatic diseases is estimated to more than Euros 200 billions per year.

The task force, comprising Europe's leading researchers and clinicians, along with observers from a patients' representative group and the European Medicines Agency, EMEA, has looked across the field, considering all aspects of basic research and clinical practice, and distilled its findings into five key recommendations. The aim is to provide coherent objectives for national and European funding bodies and healthcare providers, and ensure that rheumatic diseases are acknowledged as a major group of diseases within the European Commission Framework Programme 7.

Bertil Andersson, ESF Chief Executive said, "The ambition in this policy paper lies not only in identifying key i
'"/>

Contact: Dr. Carole Moquin-Pattey
cmoquin-pattey@esf.org
33-03-876-7173
European Science Foundation
21-Jun-2006


Page: 1 2 3

Related medicine news :

1. 1 of 2 pediatric kidney disease research centers in world established
2. Stanford researchers find culprit in aging muscles that heal poorly
3. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
4. Indiana University Imaging Center receives $6M grant for kidney research
5. Penn researchers discover novel pathway for increasing good cholesterol
6. New research discovers independent brain networks control human walking
7. Theory of facial aging gets a facelift from UT Southwestern researchers
8. Sports concussion research using fMRI provides insight for safe return-to-play decisions
9. UIC researchers to develop new drugs to fight bioterrorism
10. New research finds high prevalence of smoking among physicians in China
11. Fat is the new normal, FSU researcher says

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2019)... ... March 20, 2019 , ... Confluent ... (BRPT-Lake), a physical therapist owned outpatient physical and occupational therapy practice with seven ... Physical Therapy was founded more than 55 years ago, our mission has been ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... Santa Clara County, announced that the National Committee for Quality Assurance (NCQA) has ... of business. NCQA is a private, not-for-profit organization dedicated to improving health care ...
(Date:3/20/2019)... ... March 20, 2019 , ... Many companies are ... for safe clinical testing. , A recent publication in the Journal of Stem ... Inc. that has shown promising results for the reversal of aging. The paper, ...
(Date:3/20/2019)... Ohio (PRWEB) , ... March 20, 2019 , ... ... or back pain from disc herniation's, degenerative disc disease, spinal stenosis, sciatica ... all in one location! , At Advanced Spine Joint and Wellness provider's ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... its Crominex®3+, a composition of trivalent chromium chloride combined with extracts of amla ... function. This newly granted patent, along with 7 clinical studies on Crominex®3+, establish ...
Breaking Medicine News(10 mins):
(Date:3/20/2019)... ... March 20, 2019 , ... ... which lung cancer patients will respond to chemotherapy, according to a new study ... typically the first-line treatment of advanced-stage non–small cell lung cancer (NSCLC). However, only ...
(Date:3/20/2019)... ... March 20, 2019 , ... SmartLinx, ... Care Centre used its SmartLinx suite to refute a false allegation and immediately ... the Illinois Department of Public Health regulators alleged the facility was out of ...
(Date:3/19/2019)... ... March 19, 2019 , ... TreTap Launches First-Ever CBD Infused ... week online contest – One winner will receive TreTap beverages for a year ... CBD infused maple water beverage. Tretap, which was acquired by Vermont’s original CBD store ...
Breaking Medicine Technology:
Cached News: